525 related articles for article (PubMed ID: 12363399)
41. Intrathecal co-administration of NMDA antagonist and NK-1 antagonist reduces MAC of isoflurane in rats.
Ishizaki K; Sasaki M; Karasawa S; Obata H; Nara T; Goto F
Acta Anaesthesiol Scand; 1999 Aug; 43(7):753-9. PubMed ID: 10456816
[TBL] [Abstract][Full Text] [Related]
42. Involvement of glial cells in the nociceptive behaviors induced by a high-dose of histamine administered intrathecally.
Mizoguchi H; Komatsu T; Iwata Y; Watanabe C; Watanabe H; Orito T; Katsuyama S; Yonezawa A; Onodera K; Sakurada T; Sakurada S
Eur J Pharmacol; 2011 Feb; 653(1-3):21-5. PubMed ID: 21118680
[TBL] [Abstract][Full Text] [Related]
43. Blockade of the glycine modulatory site of NMDA receptors modifies dynorphin-induced behavioral effects.
Bakshi R; Faden AI
Neurosci Lett; 1990 Mar; 110(1-2):113-7. PubMed ID: 1970139
[TBL] [Abstract][Full Text] [Related]
44. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
[TBL] [Abstract][Full Text] [Related]
45. Spinal ERK2 activation through δ2-opioid receptors contributes to nociceptive behavior induced by intrathecal injection of leucine-enkephalin.
Komatsu T; Katsuyama S; Mizoguchi H; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
Peptides; 2014 Apr; 54():131-9. PubMed ID: 24480726
[TBL] [Abstract][Full Text] [Related]
46. Use of non-peptide tachykinin receptor antagonists to substantiate the involvement of NK1 and NK2 receptors in a spinal nociceptive reflex in the rat.
Picard P; Boucher S; Regoli D; Gitter BD; Howbert JJ; Couture R
Eur J Pharmacol; 1993 Mar; 232(2-3):255-61. PubMed ID: 7682180
[TBL] [Abstract][Full Text] [Related]
47. The non-NMDA glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione and 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline, but not NMDA antagonists, block the intrastriatal neurotoxic effect of MPP+.
Merino M; Vizuete ML; Cano J; Machado A
J Neurochem; 1999 Aug; 73(2):750-7. PubMed ID: 10428073
[TBL] [Abstract][Full Text] [Related]
48. Non-NMDA receptor antagonist attenuates antinociception induced by morphine but not beta-endorphin, D-Pen2-D-Pen5-enkephalin, and U50, 488H administered intracerebroventricularly in mice.
Suh HW; Choi YS; Yoo JS; Song DK; Kim YH; Tseng LF
Neuropeptides; 1995 Feb; 28(2):125-9. PubMed ID: 7746356
[TBL] [Abstract][Full Text] [Related]
49. Supraspinal NMDA and non-NMDA receptors are differentially involved in the production of antinociception by morphine and beta-endorphin administered intracerebroventricularly in the formalin pain model.
Chung KM; Song DK; Huh SO; Kim YH; Choi MR; Suh HW
Neuropeptides; 2000; 34(3-4):158-66. PubMed ID: 11021975
[TBL] [Abstract][Full Text] [Related]
50. Intrathecal morphine-3-glucuronide-induced nociceptive behavior via Delta-2 opioid receptors in the spinal cord.
Komatsu T; Katsuyama S; Nagase H; Mizoguchi H; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
Pharmacol Biochem Behav; 2016 Jan; 140():68-74. PubMed ID: 26476133
[TBL] [Abstract][Full Text] [Related]
51. Activation of spinal N-methyl-D-aspartate receptors stimulates a nitric oxide/cyclic guanosine 3,5-monophosphate/glutamate release cascade in nociceptive signaling.
Kawamata T; Omote K
Anesthesiology; 1999 Nov; 91(5):1415-24. PubMed ID: 10551594
[TBL] [Abstract][Full Text] [Related]
52. Potentiation of NMDA receptor-mediated responses by dynorphin at low extracellular glycine concentrations.
Zhang L; Peoples RW; Oz M; Harvey-White J; Weight FF; Brauneis U
J Neurophysiol; 1997 Aug; 78(2):582-90. PubMed ID: 9307096
[TBL] [Abstract][Full Text] [Related]
53. Dynorphin A elicits an increase in intracellular calcium in cultured neurons via a non-opioid, non-NMDA mechanism.
Tang Q; Lynch RM; Porreca F; Lai J
J Neurophysiol; 2000 May; 83(5):2610-5. PubMed ID: 10805661
[TBL] [Abstract][Full Text] [Related]
54. NMDA or non-NMDA receptor antagonists attenuate increased Fos expression in spinal dorsal horn GABAergic neurons after intradermal injection of capsaicin in rats.
Zou X; Lin Q; Willis WD
Neuroscience; 2001; 106(1):171-82. PubMed ID: 11564427
[TBL] [Abstract][Full Text] [Related]
55. Polyamine effects upon N-methyl-D-aspartate receptor functioning: differential alteration by glutamate and glycine site antagonists.
Nussenzveig IZ; Sircar R; Wong ML; Frusciante MJ; Javitt DC; Zukin SR
Brain Res; 1991 Oct; 561(2):285-91. PubMed ID: 1686987
[TBL] [Abstract][Full Text] [Related]
56. Intrathecal histamine induces spinally mediated behavioral responses through tachykinin NK1 receptors.
Sakurada S; Orito T; Furuta S; Watanabe H; Mobarakeh JI; Yanai K; Watanabe T; Sato T; Onodera K; Sakurada C; Sakurada T
Pharmacol Biochem Behav; 2003 Jan; 74(2):487-93. PubMed ID: 12479971
[TBL] [Abstract][Full Text] [Related]
57. The HIV-1 coat protein gp120 and some of its fragments potently activate native cerebral NMDA receptors mediating neuropeptide release.
Gemignani A; Paudice P; Pittaluga A; Raiteri M
Eur J Neurosci; 2000 Aug; 12(8):2839-46. PubMed ID: 10971626
[TBL] [Abstract][Full Text] [Related]
58. Role of the NMDA receptor complex in DMCM-induced seizure in mice.
Tsuda M; Suzuki T; Misawa M
Neuroreport; 1997 Feb; 8(3):603-6. PubMed ID: 9106731
[TBL] [Abstract][Full Text] [Related]
59. Evidence for the interaction of glutamate and NK1 receptors in the periphery.
Carlton SM; Zhou S; Coggeshall RE
Brain Res; 1998 Apr; 790(1-2):160-9. PubMed ID: 9593874
[TBL] [Abstract][Full Text] [Related]
60. NMDA and quisqualate modulation of visceral nociception in the rat.
Kolhekar R; Gebhart GF
Brain Res; 1994 Jul; 651(1-2):215-26. PubMed ID: 7922569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
